secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2025-08-06T23:59:59+00:00
Accession:  0001641172-25-022445
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma increases authorized common stock to 500M shares
------------------------------------------------------------------

- Authorized common shares doubled from 250M to 500M effective Aug 6, 2025.
- Shareholder approval obtained at 2025 annual meeting on June 23, 2025.
- Total authorized capital stock is now 510M shares (500M common + 10M preferred).
- Certificate of Amendment filed with Delaware Secretary of State.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225022445/0001641172-25-022445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000164117225022445/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-022445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer